Open Access
Issue
J Extra Corpor Technol
Volume 38, Number 1, March 2006
Page(s) 58 - 63
DOI https://doi.org/10.1051/ject/200638058
Published online 15 March 2006
  1. Gu YJ, de Vries AJ, Boonstra PW, Van Oeveren W. Mechanism and strategy of leukocyte depletion during cardiopulmonary bypass surgery. In: Matheis G, Moritz A, Scholz M, eds. Leukocyte Depletion in Cardiac Surgery and Cardiology. Basel: Karger Publishers; 2002;78–88. [Google Scholar]
  2. Hill JD, Osborne JJ, Swank RL, Aguilar MJ, Gerbode F, deLanerolle P. Experience using a new dacron wool filter during extracorporeal circulation. Arch Surg. 1970;101:649–52. [CrossRef] [PubMed] [Google Scholar]
  3. Patterson RH, Kessler J, Bergland RM. A filter to prevent cerebral damage during experimental cardiopulmonary bypass. Surg Gyn Obstet. 1971;132:71–4. [Google Scholar]
  4. Whitaker DC, Stygall JA, Newman SP, Harrison MJG. The use of leucocyte-depleting and conventional arterial line filters in cardiac surgery: a systematic review of clinical studies. Perfusion. 2001;16:433–46. [CrossRef] [PubMed] [Google Scholar]
  5. Kurusz M, Schneider B, Brown J, Conti V. Filtration during open heart surgery; devices techniques, opinions and complications. Proc Am Acad Cardiovasc Perf. 1983;4:123–9. [Google Scholar]
  6. Mejak BLStammers ARauch E. Vang S, Viessman T. A retrospective study on perfusion incidents and safety devices. Perfusion. 2000;15:51–61. [CrossRef] [PubMed] [Google Scholar]
  7. Kong R, Stygall J, Aveling W, Pugsley W, Harrison M, Newman S. Protection and anaesthesia for adult cardiac surgery in the UK and Ireland. Presented at the Meeting of the Association of Cardiothoracic Anaesthetists. November 1998. Cited in Whitaker DC et al. Perfusion 2001;16:433–46. [CrossRef] [PubMed] [Google Scholar]
  8. Loop FD, Szabo J, Rowlinson RD, Urbanek K. Events related to microembolism during extra-corporeal perfusion in man: effectiveness of in-line filtration recorded by ultrasound. Ann Thorac Surg. 1976;21:412–20. [CrossRef] [Google Scholar]
  9. Mitchell SJ, Willcox T, Gorman DF. Bubbles generation and venous air filtration by hard-shell venous reservoirs: a comparative study. Perfusion. 1997;12:325–33. [CrossRef] [PubMed] [Google Scholar]
  10. Padayachee TS, Parsons S, Theobold R, Gosling RG, Deverall PB. The effect of arterial filtration on reduction of gaseous microemboli in the middle cerebral artery during cardiopulmonary bypass. Ann Thorac Surg. 1988;45:647–9. [CrossRef] [Google Scholar]
  11. Barbut D, Hinton RB, Szatrowski TP, et al. Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke. 1994;25:2398–402. [CrossRef] [PubMed] [Google Scholar]
  12. Clark RE, Brillman J, Davis DA, Lovell MR, Price TR, Magovern GJ. Microemboli during coronary artery bypass grafting, Genesis and effect on outcome. J Thorac Cardiovasc Surg. 1995;109:249–58. [CrossRef] [Google Scholar]
  13. Stump DA, Rogers AT, Hammon JW, Newman SP. Cerebral emboli and cognitive outcome after cardiac surgery. J Cardiothorac Vasc Anesth. 1996;10:113–9. [CrossRef] [Google Scholar]
  14. Arrowsmith JE, Stygall J, Timberlake N, et al. Correlation between middle cerebral artery microemboli and neuropsychological deficits following cardiopulmonary bypass with a membrane oxygenator. Ann Thorac Surg. 1997;64:924. [Google Scholar]
  15. Stump DA, Fedorko L, Brooker R, Hilbawi H, Kon NA, Hammon JW. Biochemical markers of brain injury, embolic load, bypass time and neurobehavioural deficits after CABG surgery: is there a relationship. Ann Thorac Surg. 1997;64:920. [Google Scholar]
  16. Hammon JW, Stump DA, Kon ND, et al. Risk factors and solutions for the development of neurobehavioral changes after coronary artery bypass grafting. Ann Thorac Surg. 1997;63:1613–8. [CrossRef] [Google Scholar]
  17. Fearn SJ, Pole R, Wesnes K, Faragher EB, Hooper TL, McCollum CN. Cerebral injury during cardiopulmonary bypass: emboli impair memory. J Thorac Cardiovasc Surg. 2001;121:1150–60. [CrossRef] [Google Scholar]
  18. Aberg T, Kihlgren M. Cerebral protection during open heart surgery. Thorax. 1977;32:525–33. [CrossRef] [PubMed] [Google Scholar]
  19. Garvey JW, Willner A, Wolpowitz Aet al. The effect of arterial filtration during open heart surgery on cerebral function. Circulation 1983;68:125–8. [Google Scholar]
  20. Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke. 1994;25:1393–9. [CrossRef] [PubMed] [Google Scholar]
  21. Whitaker DC, Newman SP, Stygall J, Hoope-Wynn C, Harrison MJG, Walesby RK. The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg 2004;267–74. [CrossRef] [PubMed] [Google Scholar]
  22. Taggart DP, Bhattacharya K, Meston N, et al. Serum S-100 protein concentration after cardiac surgery: a randomized trial of arterial line filtration. Eur J Cardiothorac Surg. 1997;11:645–49. [CrossRef] [Google Scholar]
  23. de Vroege R, te Meerman F, Eijsman L, Wildevuur WR. Wildevuur ChRH, van Oeveren W. Induction and detection of disturbed homeostasis in cardiopulmonary bypass. Perfusion. 2004;19:267–76. [CrossRef] [PubMed] [Google Scholar]
  24. Rubens FD, Mesana T. The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Perfusion. 2004;19:S5–S12. [CrossRef] [PubMed] [Google Scholar]
  25. Zamboni WA. The microcirculation and ischemia-reperfusion: basic mechanisms of hyperbaric oxygen. In: Kindwall E, Whelan HT, eds. Hyperbaric Medicine Practice. Flagstaff AZ: Best Publishers; 1999;779–94. [Google Scholar]
  26. Smit JJ, de Vries AJ, Gu YJ, van Oeveren W. Filtration of activated granulocytes during cardiopulmonary bypass surgery: A morphological and immunological study to characterize the trapped leukocytes. J Lab Clin Med. 2000;135:238–46. [CrossRef] [Google Scholar]
  27. Matheis G, Scholz M, Simon A, Henrich D, Wimmer-Greinecker G, Moritz A. Timing of leukocyte filtration during cardiopulmonary bypass. Perfusion. 2001;16(supp):31–7. [CrossRef] [PubMed] [Google Scholar]
  28. Patel AN, Sutton SW, Livingston S, et al. Clinical benefits of leukocyte filtration during valve surgery. Am J Surg. 2003;186:636–40. [CrossRef] [Google Scholar]
  29. Chen YF, Tsai WC, Lin CC, et al. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg. 2004;78:634–42. [CrossRef] [Google Scholar]
  30. Garner JR, Stroud RE, Finklea L, Ikononmidis JS, Dorman BH, Spinale FG. The effects of leukocyte reduction on matrix metalloproteinase release in cardiopulmonary bypass. J Extra Corpor Technol. 2004;36:185–90. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  31. Sheppard SV, Gibbs RV, Smith DC. Does the use of leucocyte depletion during cardiopulmonary bypass affect exhaled nitric oxide production? Perfusion. 2004;19:7–10. [CrossRef] [PubMed] [Google Scholar]
  32. Sahlman A, Ahonen J, Salo JA, Ramo OJ. No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass. Acta Anasthesiol Scand. 2001;45:558–63. [CrossRef] [Google Scholar]
  33. Matheis G, Scholz M, Gerber J, Abdel-Rahman U, Wimmer-Greinecker G, Moritz A. Leukocyge filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury. Perfusion. 2001;16:43–9. [CrossRef] [PubMed] [Google Scholar]
  34. Baksaas ST, Flom-Halvorsen HI, Ovrum E, et al. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion. 1999;14:107–17. [CrossRef] [PubMed] [Google Scholar]
  35. deVries A, Gu YJ, Post WJ, et al. Leucocyte depletion during cardiac surgery: a comparison of different filtration strategies. Perfusion. 2003;18:31–8. [CrossRef] [PubMed] [Google Scholar]
  36. Stefanou DC, Gourlay T, Asimakopoulos G, Tayor KM. Leucodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements. Perfusion. 2001;16:51–8. [CrossRef] [PubMed] [Google Scholar]
  37. Mair P, Hoermann C, Mair J, Margreitter J, Puschendorf B, Balogh D. Effects of a leucocyte depleting arterial line filter on perioperative proteolytic enzyme and oxygen free radical release in patients undergoing aortocoronary bypass surgery. Acta Anesthesiol Scand. 1999;43:452–7. [CrossRef] [Google Scholar]
  38. Baksaas ST, Videm V, Mollnes TE, et al. Leucocyte filtration curing cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets. Perfusion. 1998;13:429–36. [CrossRef] [PubMed] [Google Scholar]
  39. Mihaljevic T, Tonz M, von Segesser LK, et al. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study. J Thorac Cardiovasc Surg. 1995;109:1138–45. [CrossRef] [Google Scholar]
  40. Scholz M, Simon A, Matheis G, et al. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res. 2002;51:363–8. [CrossRef] [PubMed] [Google Scholar]
  41. Fabbri A, Manfredi J, Piccin C, et al. Systemic leukocyte filtration during cardiopulmonary bypass. Perfusion. 2001;16:1–8. [Google Scholar]
  42. Di Salvo C, Loucca LL, Pattichis K, Hooper J, Walesby RK. Does activated neutrophil depletion on bypass by leucocyte filtration reduce myocardial damage. J Cardiovasc Surg. 1996;37(supp 6):93–100. [Google Scholar]
  43. Hachida M, Hanayama N, Okamura T, et al. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. ASAIO J. 1995;41:M291–4. [CrossRef] [PubMed] [Google Scholar]
  44. Sheppard SV, Gibbs RV, Smith DC. Does leucocyte depletion during cardiopulmonary bypass improve oxygenation indices in patients with mild lung dysfunction? Br j Anaesth. 2004;93:789–92. [CrossRef] [Google Scholar]
  45. Johnson D, Thomson D, Mycyk T, Burbridge B, Mayers I. Depletion of neutrophils by filter during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status. Chest. 1995;107:1253–9. [CrossRef] [PubMed] [Google Scholar]
  46. Karaiskos TE, Palatianos GM, Triantafillou CD, et al. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease. Ann Thorac Surg. 2004;78:1339–44. [CrossRef] [Google Scholar]
  47. Olivencia-Yurvati AH, Ferrara CA, Tierney N, Wallace N, Mallet RT. Strategic leuckocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopumonary bypass. Perfusion. 2003;18:23–31. [CrossRef] [PubMed] [Google Scholar]
  48. Gott JP, Cooper WA, Schmidt FE, et al. Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg. 1998;66:747–54. [CrossRef] [Google Scholar]
  49. Heggie A, Corder J, Crichton P, Hesford J, Bingham H, Jeffries S. Clinical evaluation of the new Pall leucocute-depleting blood cardioplegia filter (BC1). Perfusion. 1998;13:17–25. [CrossRef] [PubMed] [Google Scholar]
  50. Roth M, Kraus B, Scheffold T, Reuthebuch O, Klovekorn W, Bauer E. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg. 2000;120:642–50. [CrossRef] [Google Scholar]
  51. Palatianos GM, Balentine G, Papadakis EG, et al. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg. 2004;77:956–61. [CrossRef] [Google Scholar]
  52. Suzuki I, Ogoshi N, Chiba M, Komatsu T, Moizumi Y. Clinical evaluation of a leucocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery. Perfusion. 1998;13:205–10. [CrossRef] [PubMed] [Google Scholar]
  53. Sawa Y, Tniguchi K, Kadoba K, et al. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation. 1996;93:1640–6. [CrossRef] [PubMed] [Google Scholar]
  54. Ichihara T, Yasuura K, Maseki T, et al. The effects of using a leukocyte removal filter during cold blood cardioplegia. Surg Today. 1994;24:966–72. [CrossRef] [PubMed] [Google Scholar]
  55. Sawa Y, Matsuda H, Shimazaki Y, et al. Evaluation of leucocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108:1125–31. [CrossRef] [Google Scholar]
  56. Pearl JM, Drinkwater DC, Laks H, Capouya ER, Gates RN. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized double blind clinical trial. J Heart Lung Transplant. 1992;11:1082–92. [Google Scholar]
  57. Browning P, Pullen M, Jackson M, Rashid A. Leucocyte depleted cardioplegia does not reduce reperfusion injury in hypothermic coronary artery bypass surgery. Perfusion. 1999;14:371–7. [CrossRef] [PubMed] [Google Scholar]
  58. Martin J, Krause M, Benk C, Lutter G, Siegenthaler M, Beyersdorf F. Blood cardioplegia filtration. Perfusion. 2003;18:75–80. [CrossRef] [PubMed] [Google Scholar]
  59. Ortolano GA, Aldea GS, Lilly K, et al. A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects. Perfusion. 2002;17:53–62. [CrossRef] [PubMed] [Google Scholar]
  60. Brooker RF, Brown WR, Moody DM, et al. Cardiopulmonary suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg. 1998;65:1651–5. [CrossRef] [Google Scholar]
  61. Brown WR, Moody DM, Challa VR. Cerebral fat embolism from cardiopulmonary bypass. J Neuropathol Exp Neurol. 1999;58:109–19. [CrossRef] [PubMed] [Google Scholar]
  62. Appelblad M, Engstrom G. Fat contamination of pericardial suction blood and its influence on in vitro capillary pore flow properties in patients undergoing routine coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2002;123:381–3. [CrossRef] [Google Scholar]
  63. Svenmarker S, Engstrom KG, Karlsson T, Jansson E, Lindholm R, Aberg T. Influence of pericardial suction blood retransfusion on memory function and release of protein S100B. Perfusion. 2004;19:337–43. [CrossRef] [PubMed] [Google Scholar]
  64. Jewel AE, Akowuah EF, Survarna SK, et al. A prospective randomized comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg. 2003;23:633–6. [CrossRef] [Google Scholar]
  65. Kincaid EH, Jones TJ, Stump DA, et al. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. Ann Thorac Surg. 2000;70:1296–300. [CrossRef] [Google Scholar]
  66. Kaza AK, Cope JT, Fiser SM. Elimination of fat microemboli during cardiopulmonary bypass. Ann Thorac Surg. 2003;75:555–9. [CrossRef] [Google Scholar]
  67. Engstrom KG. The embolic potential of liquid fat in pericardial suction blood, and its elimination. Perfusion. 2003;18:69–74. [CrossRef] [PubMed] [Google Scholar]
  68. Abdel-Rahman U, Ozaslan F, Risteski PS, et al. Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit? Ann Thorac Surg. 2005;80:238–43. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.